UnitedHealth Group (UNH) Stock Forecast & Price Target

$377.98 -1.32 (-0.35%)

Closing price 03:59 PM Eastern

Extended Trading

$382.04 +4.06 (+1.07%)

As of 08:00 PM Eastern

Compare

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 28 Analyst Ratings

Sell
0

Hold
8

Buy
20

Based on 28 Wall Street analysts who have issued ratings for UnitedHealth Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 28 analysts, 8 have given a hold rating, and 20 have given a buy rating for UNH.

Consensus Price Target

$462.59
22.38% Upside

According to the 28 analysts' twelve-month price targets for UnitedHealth Group, the average price target is $462.59. The highest price target for UNH is $529.00, while the lowest price target for UNH is $255.00. The average price target represents a forecasted upside of 22.38% from the current price of $377.98.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for UNH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UNH Analyst Ratings Over Time

Type	Current Forecast 10/12/25 to 10/12/26	1 Month Ago 9/12/25 to 9/12/26	3 Months Ago 7/14/25 to 7/14/26	1 Year Ago 10/12/24 to 10/12/25
Strong Buy	0 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	20 Buy rating(s)	20 Buy rating(s)	22 Buy rating(s)	16 Buy rating(s)
Hold	8 Hold rating(s)	7 Hold rating(s)	4 Hold rating(s)	7 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$462.59	$465.75	$418.85	$383.09
Forecasted Upside	22.38% Upside	22.94% Upside	-1.49% Downside	8.13% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

UNH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

UNH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

UnitedHealth Group Stock vs. The Competition

Type	UnitedHealth Group	Healthcare Companies	Broader Market
Consensus Rating Score	2.71	2.32	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	22.38% Upside	1,031.71% Upside	19.25% Upside
News Sentiment Rating	Positive News See Recent UNH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/9/2026	New Street Research 4 of 5 stars		Set Target		$402.00	+8.49%
10/9/2026	TD Cowen 3 of 5 stars	Ryan Langston Not Rated	Lower Target	Hold	$430.00 ➝ $402.00	+8.49%
10/8/2026	Weiss Ratings 3 of 5 stars		Upgrade	Hold (C-) ➝ Hold (C)
9/14/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
9/2/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lance Wilkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$492.00 ➝ $512.00	+28.12%
8/27/2026	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Hold
7/21/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$512.00	+18.68%
7/21/2026	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$512.00	+18.68%
7/21/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lisa Gill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$466.00 ➝ $516.00	+19.23%
7/20/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ann Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$470.00 ➝ $493.00	+16.87%
Get the Latest News and Ratings for UNH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors with MarketBeat's FREE daily newsletter.
7/20/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Fischbeck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$450.00	+6.68%
7/20/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Toung Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$400.00 ➝ $470.00	+26.41%
7/20/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$429.00 ➝ $441.00	+4.52%
7/17/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$435.00 ➝ $490.00	+31.80%
7/17/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Overweight	$440.00 ➝ $495.00	+33.14%
7/17/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Windley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$401.00 ➝ $490.00	+31.79%
7/17/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Hold	$370.00 ➝ $467.00	+25.61%
7/17/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Tassan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$477.00 ➝ $499.00	+34.21%
7/17/2026	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Whit Mayo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$462.00 ➝ $472.00	+26.95%
7/17/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erin Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$468.00 ➝ $529.00	+21.54%
7/17/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Wiederhorn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$420.00 ➝ $500.00	+15.96%
7/17/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$463.00 ➝ $478.00	+10.04%
7/17/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$460.00 ➝ $490.00	+15.77%
7/16/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ha Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Underperform ➝ Neutral	$287.00 ➝ $453.00	+4.98%
7/14/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Ransom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$370.00 ➝ $460.00	+23.73%
7/14/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$440.00 ➝ $480.00	+11.38%
7/14/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Gillmor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$400.00 ➝ $475.00	+10.63%
7/13/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$397.00 ➝ $485.00	+12.82%
7/7/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$400.00 ➝ $480.00	+29.11%
7/6/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sidharth Sahoo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$300.00 ➝ $380.00	-8.56%
5/27/2026	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$492.00	+30.34%
3/10/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Outperform	$400.00 ➝ $350.00	-5.88%
5/19/2025	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$520.00 ➝ $308.00	-1.39%
12/5/2024	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Overweight	$605.00 ➝ $675.00	+10.54%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 11:25 PM ET.

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, October 12, 2026. Please send any questions or comments about these UnitedHealth Group pros and cons to contact@marketbeat.com.

UnitedHealth Group
Bull Case

Here are some ways that investors could benefit from investing in UnitedHealth Group:

UnitedHealth Group is currently trading at $377.98, which is significantly below the consensus price target of $456.56, suggesting substantial upside potential as analysts maintain a Moderate Buy rating based on recent data.
The company demonstrated strong earnings momentum by reporting $6.38 in earnings per share for the quarter ended July 16, 2026, which exceeded the consensus estimate of $4.94 by a wide margin, indicating effective cost controls and operational efficiency.
Investors can benefit from a dividend yield of 2.45%, supported by a recent quarterly dividend payment of $2.32 per share, providing a steady income stream while the company maintains a payout ratio of 59.72%.
UnitedHealth Group offers a diversified healthcare platform through its UnitedHealthcare and Optum segments, which analysts view as a competitive advantage over peers like Humana, particularly due to improving Medicare Advantage profitability and a lower valuation multiple.
Institutional confidence is growing, with several hedge funds and advisors increasing their stakes in the third quarter of 2026, such as Farther Finance Advisors LLC raising its position by 23.9% and Tactive Advisors LLC boosting its stake by 121.5%.

UnitedHealth Group
Bear Case

Investors should be bearish about investing in UnitedHealth Group for these reasons:

Revenue growth remains subdued, with the most recent quarter showing only a 0.4% year-over-year increase, which may limit the company's ability to drive top-line expansion despite margin improvements.
Medicare Advantage star-rating changes have negatively impacted UnitedHealth Group, with J.P. Morgan estimating that the company's 4-star enrollment share has fallen to 67%, potentially affecting reimbursement rates and competitive positioning against rivals like Humana.
Some analysts, such as TD Cowen, have lowered their price targets to $402, reflecting continued caution regarding the sustainability of margin repair and the company's ability to manage medical costs effectively.
The stock has experienced volatility, trading below its 50-day moving average of $388.78 and 200-day moving average of $380.29, indicating recent downward pressure and potential uncertainty in the market's perception of the stock.
Insider selling activity is notable, with CEO Patrick Conway selling 1,169 shares in August 2026 and 500 shares in August 2026, which may signal a lack of confidence from company leadership in the current stock price.

UNH Forecast - Frequently Asked Questions

According to the research reports of 28 Wall Street equities research analysts, the average twelve-month stock price forecast for UnitedHealth Group is $462.59, with a high forecast of $529.00 and a low forecast of $255.00.

28 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last year. There are currently 8 hold ratings and 20 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" UNH shares.

According to analysts, UnitedHealth Group's stock has a predicted upside of 22.38% based on their 12-month stock forecasts.

Over the previous 90 days, UnitedHealth Group's stock had 3 downgrades and 2 upgrades by analysts.

UnitedHealth Group has been rated by research analysts at Argus, Bank of America, Barclays, BMO Capital Markets, Cantor Fitzgerald, DA Davidson, Deutsche Bank Aktiengesellschaft, Erste Group Bank, Jefferies Financial Group, JPMorgan Chase & Co., KeyCorp, Leerink Partners, Mizuho, Morgan Stanley, New Street Research, Oppenheimer, Piper Sandler, Raymond James Financial, Robert W. Baird, Royal Bank Of Canada, Sanford C. Bernstein, TD Cowen, The Goldman Sachs Group, Truist Financial, UBS Group, Weiss Ratings, and Zacks Research in the past 90 days.

Analysts like UnitedHealth Group more than other "healthcare" companies. The consensus rating for UnitedHealth Group is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how UNH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With UnitedHealth Group Recommendations

MarketBeat monitors more than a dozen sources for UnitedHealth Group analyst ratings, with the most recent rating issued on 10/9/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

UNH Analyst Ratings Over Time

UNH Analyst Recommendations By Month

UNH Price Targets by Month

UnitedHealth Group Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

UnitedHealth Group
Bull Case

UnitedHealth Group
Bear Case

UNH Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With UnitedHealth Group Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

UNH Analyst Ratings Over Time

UNH Analyst Recommendations By Month

UNH Price Targets by Month

UnitedHealth Group Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

UnitedHealth Group Bull Case

UnitedHealth Group Bear Case

UNH Forecast - Frequently Asked Questions

What is UnitedHealth Group's forecast for 2026?

Should I buy or sell UnitedHealth Group stock right now?

Does UnitedHealth Group's stock price have much upside?

Has UnitedHealth Group been upgraded or downgraded by Wall Street analysts recently?

What analysts cover UnitedHealth Group?

Do Wall Street analysts like UnitedHealth Group more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With UnitedHealth Group Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

UnitedHealth Group
Bull Case

UnitedHealth Group
Bear Case